News
Investment
Research
Lifestyle
Search for:
Search
More
About us
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
juvenescence
Juvenescence and Buck Institute launch company to target heart disease
Biotech
Investment
Juvenescence and Buck Institute set the (ke)tone for metabolism and ketosis research
Biotech
Active ingredient in Juvenescence’s Metabolic Switch induces ketosis, new study finds
Biotech
Juvenescence targets fibrotic disease with new investment
Investment
G3 and Juvenescence partner on deep learning venture
AI
AI/Digital
Biotech
Development
Drugs
Investment
Investment